Viatar CTC Solutions logo

Viatar CTC Solutions

Recent Finacing

Series B

Recent Raise

Undisclosed

Viatar CTC Solutions develops the Viatar Oncopheresis System, a label-free cross-flow filtration device that removes circulating tumor cells from whole blood and enables liquid-biopsy collection and regulatory/clinical programs.

Founded 2007
Massachusetts, United States
1-10
Publicly Traded
viatarctcsolutions.com

Highlights

Focus Areas

Biotechnology
Genetics
Health Care
Health Diagnostics
Medical

Financials

$60M

Valuation as of 03/01/2016

1

Funding round